Depression and Anxiety Trial, Recruiting NCT07420101 Sponsor: Kimberley Roche Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07420101
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who can understand spoken English and read written English
  • People who are 18 years of age or older
  • People who are able to understand the study information and are willing to sign a consent form
  • People who have access to a smartphone or tablet that can receive text messages
  • People who are a caregiver for a cancer patient of any age, including patients who are adults
  • People who are caring for a cancer patient who has a routine scan (such as a CT, MRI, or PET scan) scheduled within the next 3 months
  • People who, if placed in the Phase 2 group, are willing and able to eat a raisin (raisins would be mailed to the home address)

Who may not be able to join:

  • People whose cancer patient is an adult who is caring for themselves (i.e., there is no separate caregiver)
  • People who have a medically diagnosed cognitive delay, as disclosed by the person themselves on an eligibility questionnaire
  • People whose upcoming scan is urgent and related to concern that the cancer may have come back
  • People whose upcoming scan is part of the first round of tests to diagnose or investigate cancer
  • People whose upcoming scan is not a routine surveillance scan

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kimberley Roche, MSN, PPCNP-BC, APRN, Connecticut Children's Medical Center

Phone: 860-545-9671

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kimberley Roche
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
1 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Likert-Style Anxiety Scale; State-Trait Anxiety Inventory (STAI); Feasibility of the Program; Acceptability of Intervention Measure (AIM); Intervention Appropriateness Measure (IAM); Feasibility of Intervention Measure (FIM)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov